STE (Steris) Marketable Securities: $0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STE Steris PLC STE
91 GF Score
Price $236.12
GF Value $269.10
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Steris Marketable Securities?

Steris STE +1.60% 91 Marketable Securities is $0 Mil as of Jun. 2026. GuruFocus rates STE with a GF Score™ of 91/100 and a GF Value™ of $269.10 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Steris's Marketable Securities for the quarter that ended in Jun. 2026 was $0 Mil.

Steris  (NYSE:STE) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Steris Marketable Securities Related Terms

Steris Marketable Securities Historical Data

* Premium members only.

The historical data trend for Steris's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steris Marketable Securities Chart

Steris Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Steris Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STE
91GF Score
Steris PLC STE
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steris Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0 Mil mean?
Steris (STE) has a Marketable Securities of $0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Steris and its competitors.
Is Steris' Marketable Securities too high?
Steris' current Marketable Securities is $0 Mil. Overall, Steris has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Steris' Marketable Securities compare to ZBH and GEHC?
Steris' Marketable Securities of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Steris and its competitors. Steris's current Marketable Securities is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Based on GuruFocus' analysis, Steris (STE) is currently considered Modestly Undervalued. The stock's GF Value™ is $269.10, compared to a current price of $236.12 — trading 12.3% below its estimated fair value. The current Marketable Securities is $0 Mil. Steris' overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Steris (STE), the current Marketable Securities is $0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Steris (STE) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of $236.12 is trading 12.3% below its estimated GF Value™ of $269.10. GuruFocus considers Steris to be Modestly Undervalued.

Key valuation signals for STE:

  • Marketable Securities: $0 Mil
  • GF Value™: $269.10 vs. price of $236.12 (12.3% below fair value)
  • GF Score™: 91/100 with 1 warning sign

No single metric tells the full story. See the STE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Steris Business Description

Other Exchanges 2TG:GermanyS1TE34:Brazil
Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
91GF Score

Get the complete analysis for STE

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$236.12
Price
$269.10
GF Value